CYTOKINETICS
Live / Registered — Registered and renewed (as of 11 Sept 2023)
What this means for you
Registered since 19 Feb 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 Feb 2023).
Record
- Serial number
- 77704212
- Registration number
- 4292577
- Mark type
- Stylized text
- Filed
- 01 Apr 2009
- Published for opposition
- 22 Sept 2009
- Registered
- 19 Feb 2013
- Next maintenance due
- 19 Feb 2023
- Attorney of record
- B. Brett Heavner
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceuticals for the treatment of neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction, skeletal muscle wasting, skeletal muscle atrophy, or skeletal muscle weakness
Owner
- Cytokinetics, Inc., South San Francisco, CA, US
- Cytokinetics, Inc., South San Francisco, CA, US
- Cytokinetics, Inc., South San Francisco, CA, US
Prior registrations
Prosecution history
- 11 Sept 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 11 Sept 2023 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 11 Sept 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 11 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Mar 2023 — TEAS SECTION 8 & 9 RECEIVED
- 19 Feb 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 24 Sept 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 24 Sept 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Sept 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Aug 2019 — TEAS SECTION 8 & 15 RECEIVED
- 19 Feb 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Feb 2013 — REGISTERED-PRINCIPAL REGISTER
- 18 Jan 2013 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Jan 2013 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 16 Jan 2013 — ASSIGNED TO LIE